Half Yearly Report and Accounts

Open PDF
Stock Rocketboots Ltd (ROC.ASX)
Release Time 27 Feb 2026, 12:57 p.m.
Price Sensitive Yes
 RocketBoots Ltd reports H1 2025 results
Key Points
  • Net loss of A$2.36M for H1 2025, down 71.75% from prior year
  • Secured A$9.1M annual recurring revenue contract with tier-one retailer
  • Raised A$7.025M through share placement to fund international expansion
Full Summary

RocketBoots Limited ('RocketBoots', the 'Company') continued delivery and commercial execution of its AI- and cloud-based software-as-a-service ('SaaS') platform, designed to enable enterprise retailers and retail banks to continually adapt their in-person channels to rapidly changing customer behaviour. Although the Company recorded a net loss of A$2,359,974 for the half-year period ended 31 December 2025, RocketBoots successfully secured an agreement with a tier-one multinational retailer to deploy loss prevention software across approximately 40% of the customer's network. The rollout is planned for calendar year 2026 and has a contract value of ~A$9.1M of annual recurring revenue. Additionally, the year saw RocketBoots convert trial to rollout, secure renewals from existing clients and signed an agreement to trial workforce software for a Mexican bank. RocketBoots announced a $7.025M placement in December 2025 to fund the rollout of its international expansion. The placement was well supported by existing and new investors, and saw four new institutions join the register. $1M was received in December 2025, a further $6M in January 2026 and the balance subject to shareholder approval. The Company appointed Ms Maria Phillips as Chief Financial Officer and Chief Operating Officer, effective 1 November 2025.

Guidance

The rollout of the A$9.1M annual recurring revenue contract with a tier-one multinational retailer is planned for calendar year 2026.

Outlook

RocketBoots is focused on executing the rollout of its transformational A$9.1M annual recurring revenue contract with a tier-one retailer in calendar year 2026, as well as continuing to drive growth through converting trials to rollouts, securing renewals, and expanding into new markets and verticals.